TIGASOL INJ

Product Description

TIGASOL INJ is a premium injectable formulation containing Tigecycline 50mg, a broad-spectrum glycylcycline antibiotic known for its potent activity against multidrug-resistant (MDR) bacterial infections. Specially designed for hospital use and critical care, TIGASOL INJ offers a powerful solution for the treatment of complicated intra-abdominal infections, skin and soft tissue infections, and certain drug-resistant respiratory tract infections.Formulated under WHO-GMP certified conditions, TIGASOL INJ is ideal for medical distributors, bulk pharmaceutical buyers, and hospital procurement departments seeking reliable, high-efficacy injectable antibiotics.Key Benefits: Contains Tigecycline 50mg effective against MDR pathogens Ideal for ICU settings and hospital-based infection management Broad-spectrum coverage including MRSA, VRE, and ESBL-producing organisms Stable, ready-to-use vial for intravenous administration Backed by quality assurance and strict manufacturing protocols Indications: Complicated intra-abdominal infections (cIAIs) Complicated skin and soft tissue infections (cSSTIs) Effective against community-acquired bacterial pneumonia (CABP) Why Choose TIGASOL INJ? Trusted in critical care antibiotic therapy High demand among hospital pharmacists and institutional buyers Suitable for bulk orders, tenders, and pharma B2B trade Prompt delivery and competitive pricing for distributors